therapies for autoimmune diseases

The future of medicine lies in the intersection of biology and technology, and we are committed to pioneering that future.

More about us

About PolTREG

The first administration of TREGs in humans

17 years of experience in cell therapies

The first in the race to the market

Phase 2 study successfully completed in type 1 diabetes

Partner of choice in autoimmune diseases

Expertise, people and production facility



Our mission is to develop effective cell therapies for the treatment of autoimmune diseases that positively impact the quality of life for patients and their families.



Our vision for growth is to cooperate with global partners to commercialize next-generation therapies for autoimmune diseases.